Dipyridamole


- TRADE NAMES: Aggrenox (Boehringer Ingelheim); Cardoxin; Cleridium; Coronarine; Coroxin; Curantyl N; Dipridacot; Lodimol; Novo-Dipiradol; Persantin; Persantine (Boehringer Ingelheim)
- INDICATIONS: Thromboembolic complications following cardiac valve replacement
- CLASS: Adenosine reuptake inhibitor, Antiplatelet
- HALF-LIFE: 10–12 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Adenosine, Ceftobiprole, Clopidogrel, Enoxaparin, Fondaparinux, Regadenoson, Reteplase, Riociguat, Tinzaparin
PREGNANCY CATEGORY: B
Aggrenox is dipyridamole and aspirin.
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTHER.
Page last updated 01/17/2022
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations 
- Breast feeding
- Geriatric
- Pediatric